(Q47869320)

6 February 2018

title

CD154 regulates primate humoral immunity to influenza (English)

1 reference

6 February 2018

author

James E. Crowe, Jr.

1

1 reference

6 February 2018

author name string

Edith C Sannella

2

1 reference

6 February 2018

Steffen Pfeiffer

3

1 reference

6 February 2018

George L Zorn

4

1 reference

6 February 2018

Agnes Azimzadeh

5

1 reference

6 February 2018

Roland Newman

6

1 reference

6 February 2018

Geraldine G Miller

7

1 reference

6 February 2018

Richard N Pierson

8

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 February 2018

American Journal of Transplantation

published in

1 reference

6 February 2018

volume

3

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

680-688

1 reference

6 February 2018

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Respiratory virus infections in bone marrow transplant recipients: the European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Antibody response to influenza immunization in patients after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Mice deficient for the CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00106.X

7 January 2021

10.1034/J.1600-6143.2003.00106.X

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018